[Psychological conditions of patient's decision to break off the treatment with atypical neuroleptic: a case study].
Patient's compliance is an important factor in treatment of schizophrenia. As a part of a wide field of compliance problems, subjective experiences of neuroleptic therapy are important for adherence to treatment. Not only pharmacological action of the given drug but also the patient's subjective and psychological experiences of this action and his/her interpretations of what he/she feels are crucial for the successful treatment of schizophrenia. The change in patient's mental state is followed by changes in patient's intrapsychic attitudes, thoughts and emotions, in his/her relationship with the important persons in environment and with the global social milieu as well. In this paper the case of a psychotic patient was described. The patient responded well to low doses of risperidone but then refused to continue the treatment. Her refusal can be understood in terms of her inability to face developmental tasks (separation process) and interpreted in psychodynamic manner. It is also clear that it has transferential meaning. In conclusions the '"awakening" problem' is described. In some cases after treatment with atypical neuroleptics good clinical improvement can be seen. Sometimes it is coined as "awakening". Many "awakened" patients experience novel set of challenges after reduction in psychotic symptoms. If it is too difficult for them to try to solve these problems, like it was in the case described above, they can drop out the treatment.
Murawiec
S
S
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003657:Decision Making; D005260:Female; D006801:Humans; D010349:Patient Compliance; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents